Name | Garazhno-stroitel'nyy kooperativ N 949 |
|---|
INN | 6318320282 |
|---|
KPP | 631801001 |
|---|
OGRN | 1036300771891 |
|---|
OKPO | 40992616 |
|---|
Address | 443066, Samarskaya Oblast', g. Samara, ul. Zaporozhskaya, d. D. 24A |
|---|
Phone | +7 (902) 293-60-43 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 94.99 | Core activity | Other membership organizations nec |
Registration date | 20.01.2003 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram po Sovetskomu rayonu goroda Samary |
|---|
|
GSK-949 (Samara Oblast; INN 6318320282) was registered on 20 Jan 2003. Type of ownership of GSK-949 - Comsumer cooperatives. Form of ownership of GSK-949 - Private property. Principal activities of GSK-949: other membership organizations nec (94.99). |
Economic indicators2023
Net loss (RAS) of GSK-949 dropped over 2023 by 2.74% to 1.24 million RUB from 1.28 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 8.56% to 1.54 million RUB from 1.41 million RUB over 2022. 2022
Net loss (RAS) of GSK-949 increased by 28.83% to 1.28 million RUB from 992.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 5.44% to 1.41 million RUB from 1.34 million RUB over 2021. 2021
Net loss (RAS) of GSK-949 dropped over 2021 by 17.26% to 992.00 thousand RUB from 1.20 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 6.77% to 1.34 million RUB from 1.26 million RUB over 2020. 2020
Net loss (RAS) of GSK-949 increased by 27.15% to 1.20 million RUB from 943.00 thousand RUB over 2019, the company informed. Revenue remained in the accounting period at the same level and made up 1.26 million RUB compared to 1.25 million RUB 1.25 million RUB. 2019
Net loss (RAS) of GSK-949 dropped over 2019 by 49.87% to 943.00 thousand RUB from 1.88 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 2.20% to 1.25 million RUB from 1.23 million RUB over 2018. 2018
Net loss (RAS) of GSK-949 increased 2.15 times to 1.88 million RUB from 875.00 thousand RUB over 2017, the company informed. Revenue decreased in the accounting period by 10.04% to 1.23 million RUB from 1.36 million RUB in 2017; cost of goods sold grew by 39.65% to 3.02 million RUB from 2.16 million RUB; sales loss grew 2.25 times to 1.79 million RUB from 795.00 thousand RUB. 2017
Net loss (RAS) of GSK-949 increased by 6.32% to 875.00 thousand RUB from 823.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 9.12% to 1.36 million RUB from 1.25 million RUB over 2016; cost of goods sold grew by 7.20% to 2.16 million RUB from 2.01 million RUB; sales loss grew by 4.06% to 795.00 thousand RUB from 764.00 thousand RUB. 2016
Net loss (RAS) of GSK-949 increased by 25.65% to 823.00 thousand RUB from 655.00 thousand RUB over 2015, the company informed. Revenue decreased in the accounting period by 6.79% to 1.25 million RUB from 1.34 million RUB in 2015; cost of goods sold grew by 4.35% to 2.01 million RUB from 1.93 million RUB; sales loss grew by 29.71% to 764.00 thousand RUB from 589.00 thousand RUB. 2014
Net loss (RAS) of GSK-949 increased by 10.87% to 612.00 thousand RUB from 552.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 2.70% to 1.33 million RUB from 1.29 million RUB over 2013; cost of goods sold grew by 4.85% to 1.88 million RUB from 1.79 million RUB; sales loss grew by 10.44% to 550.00 thousand RUB from 498.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|